AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2012

May 29, 2012

30583_dirs_2012-05-29_cbfd6c0c-6387-4658-b1dd-07f4857c3348.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-29

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities owned	0	Direct